本文へ移動
cccskills
無料GitHub で公開

enda-test-pai-acutely-ill-symptoms

Recommends diagnostic testing to exclude primary adrenal insufficiency (PAI) in acutely ill patients presenting with otherwise unexplained volume depletion, hypotension, hyponatremia, hyperkalemia, fever, abdominal pain, hyperpigmentation, or hypoglycemia (especially in children). Use when clinical suspicion arises from these suggestive signs or symptoms suggestive of PAI.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.7 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Test for PAI in Acutely Ill Patients with Suggestive Symptoms

STEP 1 — Gather Information

Collect history of acute illness, vital signs (BP, HR, temp), physical exam for volume depletion, hyperpigmentation; order basic labs: serum Na+, K+, glucose, cortisol, ACTH if available.
If any suggestive symptom is present, advance to Step 2; otherwise, consider alternative diagnoses and do not pursue PAI testing.

STEP 2 — Rule In / Rule Out

Assess for presence of unexplained volume depletion, hypotension, hyponatremia, hyperkalemia, fever, abdominal pain, hyperpigmentation, or hypoglycemia (especially in children).
If at least one is present, proceed to Step 3; if none are present, consider other diagnoses and do not test for PAI.

STEP 3 — Classify or Stratify

Determine feasibility of short corticotropin stimulation test (250 µg ACTH).
If feasible, order the test; if not feasible, obtain morning plasma cortisol and ACTH as initial screening.

STEP 4 — Decide

Interpret results: short test peak cortisol <500 nmol/L (18 µg/dL) indicates PAI; morning cortisol <140 nmol/L (5 µg/dL) with ACTH >2× ULN suggests PAI.
If PAI confirmed, initiate stress-dose hydrocortisone and arrange definitive replacement; if not confirmed, exclude PAI and investigate other causes.

Clinical Guardrails / Mimics / Pitfalls

Do not delay empiric stress-dose hydrocortisone in suspected adrenal crisis while awaiting test results; avoid using random cortisol to rule out PAI; be cautious interpreting cortisol in pregnancy, estrogen therapy, or CBG deficiency; do not use dexamethasone for PAI treatment due to lack of mineralocorticoid activity and Cushingoid risk; do not rely solely on symptoms without biochemical confirmation.

Concrete Clinical Example

A 4‑year‑old with fever, vomiting, hypotension, hyponatremia, hyperkalemia, and hypoglycemia. Morning cortisol 80 nmol/L, ACTH 120 pmol/L (elevated). Short ACTH stim test: peak cortisol 300 nmol/L at 60 min (<500). Diagnosis PAI. Patient received IV hydrocortisone 50 mg/m² bolus then continuous infusion, with clinical improvement.

Source: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-1710

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する